Nitroglycerin Teav (Glyceryl Trinitrate)

Nitroglycerin Teav, an organic nitrate, is used in the management of coronary artery disease‑related conditions.

• Angina pectoris: provides rapid relief of chest pain by improving myocardial blood flow.
• Chronic stable angina: reduces frequency of angina episodes during daily activities.
• Prophylaxis of angina attacks: prevents occurrence of angina episodes when used regularly.

• Glyceryl trinitrate is enzymatically converted to nitric oxide within vascular smooth muscle. The nitric oxide activates guanylate cyclase, increasing cyclic GMP levels, which leads to relaxation of arterial and venous smooth muscle. This vasodilation reduces preload and afterload, lowers myocardial oxygen demand, and improves coronary blood flow, thereby alleviating ischemic chest pain. The effect is dose‑dependent and occurs within minutes after patch application.

Nitroglycerin Teav may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Headache: throbbing pain often occurring shortly after application.
• Flushing: warmth and redness of the face or upper body.
• Dizziness: light‑headed sensation, especially when standing quickly.
• Hypotension: mild drop in blood pressure causing faintness.
• Nausea: upset stomach or feeling of queasiness.
• Skin irritation: redness or itching at the patch site.
• Vision changes: blurred vision.

Serious or Rare Side Effects

• Severe hypotension: marked blood pressure fall leading to syncope.
• Methemoglobinemia: abnormal hemoglobin affecting oxygen delivery.
• Allergic reaction: rash, swelling, or difficulty breathing.
• Tachycardia: rapid heart rate that may be symptomatic.
• Chest pain worsening: paradoxical increase in angina.
• Life‑threatening arrhythmias: rare but possible cardiac rhythm disturbances.

When prescribing Nitroglycerin Teav, clinicians should observe several safety measures to minimize risks.

• Assess cardiovascular status: evaluate blood pressure and heart rate before initiating therapy.
• Avoid concurrent use with phosphodiesterase‑5 inhibitors: risk of profound hypotension.
• Monitor for tolerance: efficacy may decrease with continuous use; consider drug‑free intervals.
• Educate patients on proper patch placement: apply to clean, dry, hair‑free skin and rotate sites.
• Counsel on orthostatic precautions: rise slowly to reduce dizziness.
• Store at room temperature: keep below 25°C in original packaging, protect from moisture and direct sunlight.

Nitroglycerin Teav can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• Phosphodiesterase‑5 inhibitors (e.g., sildenafil): may cause severe hypotension.
• Other organic nitrates or nicorandil: additive vasodilatory effect leading to dangerous blood pressure drop.
• Systolic blood pressure‑lowering agents (e.g., hydralazine): increased risk of hypotension.

Moderate Interactions (Monitor Closely)

• Antihypertensive drugs (beta‑blockers, ACE inhibitors): may enhance blood pressure‑lowering effect.
• Diuretics: can potentiate orthostatic hypotension.
• Alcohol: may increase vasodilatory response and dizziness.